Effect of Hemodiafiltration on Pregnancy-Associated Plasma Protein A (PAPP-A) and Related Parameters

REFERENCES

• Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR, Jr, Virmani R, Oxvig C, Schwartz RS. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022–1029, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lund J, Qiu-Ping Q, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P, Pulkki K. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003; 108: 1924–1926, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM, CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005; 45: 229–237, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Cosin-Sales J, Kaski JC, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, Cole D, Holt DW. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur J Heart J 2005; 26: 2093–2098, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kalousova M, Sulkova S, Fialova L, Soukupova J, Malbohan IM, Spacek P, Braun M, Mikulikova L, Fortova M, Horejsi M, Tesar V, Zima T. Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant 2003; 18: 2577–2581, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fialova L, Kalousova M, Soukupova J, Sulkova S, Merta M, Jelinkova E, Horejsi M, Sramek P, Malbohan I, Mikulikova L, Tesar V, Zima T. Relationship of pregnancy-associated plasma protein A (PAPP-A) to renal function and dialysis modalities. Kidney Blood Press Res 2004; 27: 88–95, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kalousova M, Horejsi M, Fialova L, Soukupova J, Sulkova S, Malbohan I, Tesar V, Zima T. Increased levels of pregnancy-associated plasma protein A (PAPP-A) are associated with mortality of hemodialysis patients: preliminary results. Blood Purif 2004; 22: 298–300, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR, III, Conover CA. The insulin-like growth factor-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy associated plasma protein-A. Proc Natl Acad Sci 1999; 96: 3149–3153, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jones JI, Prevette T, Gockerman A, Clemmons DR. Ligand occupancy of the αVβ3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 1996; 96: 2482–2487, [CROSSREF], [CSA]
   Google Scholar
• Renier G, Clement I, Desfaits AC, Lambert A. Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-α production. Endocrinology 1996; 137: 4611–4618, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Katsuda S, Kaji T. Atherosclerosis and extracellular matrix. J Atheroscler Tromb 2003; 10: 267–274, [CSA]
   PubMedGoogle Scholar
• Watanabe N, Ikeda U. Matrix metalloproteinase and atherosclerosis. Curr Atheroscler Rep 2004; 6: 112–120, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. Matrix metalloproteinases, inflammation and atherosclerosis: Therapeutic perspectives. Clin Chem Lab Med 2004; 42: 121–131, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smiega M, Hafner G, Meyer J, Cambien F, Tiret L, Investigators AtheroGene. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579–1585, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kalousova M, Lachmanova J, Mokrejsova M, Mikova B, Fialova L, Malbohan IM, Tesar V, Zima T. Pregnancy-associated plasma protein A during hemodialysis with polyamide and diacetate cellulosic membranes. Int J Artif Organs 2004; 27: 943–948, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hodkova M, Kalousova M, Dusilova-Sulkova S, Malbohan IM, Zima T. Intravenous iron gluconate administration increases circulating PAPP-A in haemodialysis patients. Ren Fail 2005; 27: 707–711, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Davey MW, Teisner B, Sonisich M, Grudzinskas JG. Interaction between heparin and human pregnancy-associated plasma protein A (PAPP-A): a simple purification procedure. Anal Biochem 1983; 131: 18–24, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 1993; 268: 12243–12246, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Qin QP, Christiansen M, Petterson K. Point-of-care time-resolved immunofluorimetric assay for human pregnancy associated plasma protein A (PAPP-A) for use in first-trimester screening for Down syndrome. Clin Chem 2002; 48: 473–483, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Qin QP, Laitinen P, Majamaa-Voltti K, Ericksson S, Kumpula EK, Pettersson K. Release patterns of pregnancy-associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc. J 2002; 36: 358–361, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006; 24: 163–173, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bohé J, Joly MO, Arkouche W, Laville M, Fouque D. Haemodialysis with biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3. Nephrol Dial Transplant 2001; 16: 590–594, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ebihara I, Nakamura T, Tomino Y, Shimada N, Koide H. Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Nephrol 1998; 18: 305–310, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakamura T, Matsuda T, Suzuki Y, Ueda Y, Koide H. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with atherosclerosis obliterans. ASAIO J 2003; 49: 430–434, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar